Biology of Insulin-Like Growth Factors in Development

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 69, Issue 4, 2003, Pages 257-271

  Dupont, Joëlle ^a   Holzenberger, Martin ^b  

^a CEMAGREF   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADIPOSE TISSUE; AGING; BONE; BRAIN; CARTILAGE; EMBRYO DEVELOPMENT; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; HUMAN; KNOCKOUT MOUSE; LIFESPAN; MOLECULAR BIOLOGY; MUSCLE; NONHUMAN; OVARY; PANCREAS; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SKIN; TRANSGENIC MOUSE;

AGING; ANIMALS; LIFE EXPECTANCY; MICE; ORGANOGENESIS; RECEPTOR, IGF TYPE 1; RECEPTOR, IGF TYPE 2; SOMATOMEDINS;

MAMMALIA; VERTEBRATA;

EID: 0347915658     PISSN: 1542975X     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdrc.10022     Document Type: Review

References (169)

1. Adams GR, NcCue SA. 1998. Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats. J Appl Physiol 84:1716-1722.
2. Adashi EY, Resnick CE, D'Ercole AJ, et al. 1985. Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocr Rev 6:400-420.
3. Alexandrides T, Moses AC, Smith RJ. 1989. Developmental expression of receptors for insulin, insulin-like growth factor I (IGF-I), and IGF-II in rat skeletal muscle. Endocrinology 124:1064-1076.
4. Arai T, Busby W Jr, Clemmons DR. 1996. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix. Endocrinology 137:4571-4575.
5. Araki E, Lipes MA, Patti ME, et al. 1994. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186-190.
6. Baker I, Liu JP, Robertson EJ, Efstradiatis A. 1993. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73-82.
7. Baker I, Hardy MP, Zhou I, et al. 1996. Effects of an Igf1 gene null mutation on mouse reproduction. Mol Endocrinol 10:903-918.
8. Barres BA, Hart IK, Coles HS, et al. 1992. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70:31-46.
9. Barton-Davis ER, Shoturma DI, Musaro A, et al. 1998. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci USA 95:15603-15607.
10. Bates P, Fisher R, Ward A, et al. 1995. Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II). Br J Cancer 72:1189-1193.
11. Baxter RC. 1988. Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex. J Clin Endocrinol Metab 67:265-272.
12. Baxter RC. 1994. Insulin-like growth factor binding proteins in the human circulation: a review. Horm Res 42:140-144.
13. Beck F, Samani NJ, Byrne S, et al. 1988. Histochemical localization of IGF-I and IGF-II MRNA in the rat between birth and adulthood. Development 104:29-39.
14. Beck KD, Powell-Braxton L, Widmer HR, et al. 1995. IGF1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatial parvalbumin-containing neurons. Neuron 14:717-730.
15. Behringer RR, Lewin TM, Quaife CJ, et al. 1990. Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone-deficient transgenic mice. Endocrinology 127:1033-1040.
16. Blüher M, Kahn BB, Kahn CR. 2003. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299:572-574.
17. Böhni R, Riesgo-Escovar I, Oldham S, et al. 1999. Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS1-4. Cell 97:865-875.
18. Boisclair YR, Hurst KR, Ueki I, et al. 2000. Regulation and role of the acid-labile subunit of the 150-kilodalton insulin-like growth factor complex in the mouse. Pediatr Nephrol 14:562-566.
19. Bonnette SG, Hadsell DL. 2001. Targeted disruption of the IGF-I receptor gene decreases cellular proliferation in mammary terminal end buds. Endocrinology 142:4937-4945.
20. Brown-Borg HM, Borg KE, Meliska CJ, Bartke A. 1996. Dwarf mice and the ageing process. Nature 384:33.
21. Burks DI, White MF. 2001. IRS proteins and beta-cell function. Diabetes 50: S140-S145.
22. Cai D, Dhe-Paganon S, Melendez PA, et al. 2003. Two new substrates in insulin signaling, IRS5/DOK4 and IRS6/DOK5. J Biol Chem 278:25323-25330.
23. Canalis E. 1993. Insulin-like growth factors and the local regulation of bone formation. Bone 14:273-276.
24. Cara JF, Rosenfield RL. 1988. Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology 123:733-739.
25. Carson MJ, Behringer RR, Brinster RL, McMorris FA. 1993. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron 10:729-740.
26. Chakravarthy MV, Davis BS, Booth FW. 2000. IGF-I restores satellite cell proliferative potential in immobilized old skeletal muscle. J Appl Physiol 89:1365-1379.
27. Chihara K, Sugimoto T. 1997. The action of GH/IGF-I/IGFBP in osteoblasts and osteoclasts. Horm Res 48:45-49.
28. Clancy DJ, Gems D, Harshman LG, et al. 2001. Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292:104-106.
29. Clemmons DR. 1998. Role of insulin-like growth factor binding proteins in controlling IGF actions. Mol Cell Endocrinol 140:19-24.
30. Coleman ME, DeMayo F, Yin KC, et al. 1995. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J Biol Chem 270:12109-12116.
31. Conover CA, Bale LK, Clarkson JT, Torring O. 1993. Regulation of insulin-like growth factor binding protein-5 messenger ribonucleic acid expression and protein availability in rat osteoblast-like cells. Endocrinology 132:2525-2530.
32. Conover CA. 2000. In vitro studies of insulin-like growth factor I and bone. Growth Horm IGF Res 10:S107-S110.
33. Constancia M, Hemberger M, Hughes J, et al. 2002. Placenta-specific IGF-II is a major modulator of placenta and fetal growth. Nature 417:945-948.
34. Coschigano KT, Clemmons D, Bellushi LL, Kopchick JJ. 2000. Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology 141:2608-2613.
35. Crossey PA, Pillai CC, Miell JP. 2002. Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice. J Clin Invest 110:411-418.
36. Daughaday WH, Rotwein P. 1989. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 10:68-91.
37. DeChiara T, Efstratiadis A, Robertson E. 1990. A growth deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345:78-80.
38. DeChiara TM, Robertson EJ, Efstratiadis A. 1991. Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64:849-859.
39. Delbe J, Blat C, Desauty G, Harel L. 1991. Presence of IDF45 (mlGFBP-3) binding sites on chick embryo fibroblasts. Biochem Biophys Res Commun 179:495-501.
40. De Los Rios P, Hill DJ. 2000. Expression and release of insulin-like growth factor binding proteins in isolated epiphyseal growth plate chondrocytes from the bovine fetus. J Cell Physiol 183:172-181.
41. D'Ercole AJ, Dai Z, Xing Y, et al. 1994. Brain growth retardation due to the expression of human insulin-like growth factor binding protein-1 in transgenic mice: an in vivo model for the analysis of IGF function in the brain. Brain Res Dev Brain Res 82:213-222.
42. D'Ercole AJ, Ye P, Calikoglu AS, Gutierrez-Ospina G. 1996. The role of the insulin-like growth factors in the central nervous system. Mol Neurobiol 13:227-255.
43. D'Ercole AJ, Ye P, O'Kusky JR. 2002. Mutant mouse models of insulin-like growth factor actions in the central nervous system. Neuropeptides 36:209-220.
44. Devedjian JC, George M, Casellas A, et al. 2000. Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes. J Clin Invest 105:731-740.
45. Dheen ST, Rajkumar K, Murphy LJ. 1996. Effects of insulin-like growth factors (IGF) on pancreatic islet function in IGF binding protein-1 transgenic mice. Diabetologia 39:1249-1254.
46. Dupont J, Renou JP, Shani M, et al. 2002. PTEN overexpression suppresses proliferation and differentiation and enhances apoptosis of the mouse mammary epithelium. J Clin Invest 110:815-825.
47. Ewton DZ, Coolican SA, Mohan S, et al. 1998. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5. J Cell Physiol 177:47-57.
48. Farrelly N, Lee YJ, Oliver J, et al. 1999. Extracellular matrix regulates apoptosis in mammary epithelium through a control on insulin signaling. J Cell Biol 144:1337-1348.
49. Ferguson MW, Sharpe PM, Thomas BL, Beck F. 1992. Differential expression of insulin-like growth factors I and II (IGF I and II), mRNA, peptide and binding protein 1 during mouse palate development: comparison with TGF beta peptide distribution. J Anat 181:219-238.
50. Fernandez AM, Dupont J, Farrar RP, ete al. 2002. Muscle-specific inactivation of the IGF-I receptor induces compensatory hyperplasia in skeletal muscle. J Clin Invest 109:347-355.
51. Ferry RJ Jr, Katz LE, Grimberg A, et al. 1999. Cellular actions of insulin-like growth factor binding proteins. Horm Metab Res 31:192-202.
52. Florini JR, Ewton DZ, Coolican SA. 1996. Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 17:481-517.
53. Font de Mora J, Esteban LM, Burks DJ, et al. 2003. Ras-GRF1 signaling is required for normal beta-cell development and glucose homeostasis. EMBO J 22:3039-3049.
54. Froment P, Seurin D, Hembert S, et al. 2002. Reproductive abnormalities in human IGF binding protein-1 transgenic female mice. Endocrinology 143:1801-1808.
55. Gems D, Partridge L. 2001. Insulin/IGF signalling and ageing: seeing the bigger picture. Curr Opin Genet Dev 11:287-292.
56. George M, Ayuso E, Casellas A, et al. 2002. Beta cell expression of IGF-I leads to recovery from type 1 diabetes. J Clin Invest 109:1153-1163.
57. Gil EB, Malone Link E, Liu LX, et al. 1999. Regulation of the insulin-like developmental pathway of Caenorhabditis elegans by a homolog of the PTEN tumor suppressor gene. Proc Natl Acad Sci U S A 96:2925-2930.
58. Giudice LC. 1992. Insulin-like growth factors and ovarian follicular development. Endocr Rev 13:641-669.
59. Giudice LC, de Zegher F, Gargosky SE et al. 1995. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 80:1548-1555.
60. Guarente L, Kenyon C. 2000. Genetic pathways that regulate ageing in model organisms. Nature 408:255-262.
61. Guler HP, Schmid C, Zapf J, Froesch ER. 1989. Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sci U S A 86:2868-2872.
62. Gutierrez-Ospina G, Calikoglu AS, Ye P, D'Ercole AJ. 1996. In vivo effects of insulin-like growth factor-I on the development of sensory pathways: analysis of the primary somatic sensory cortex (S1) of transgenic mice. Endocrinology 137:5484-5492.
63. Hadsell DL, Greenberg NM, Fligger JM, et al. 1996. Targeted expression of des(1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression. Endocrinology 137:321-330.
64. Hayden JM, Mohan S, Baylink DJ. 1995. The insulin-like growth factor system and the coupling of formation to resorption. Bone 17:93S-98S.
65. Hermanto U, Zong CS, Li W, Wang LH. 2002. RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix. Mol Cell Biol 22:2345-2365.
66. Hill DJ, Sedran RJ, Brenner SL, McDonald TJ. 1997. IGF-I has a dual effect on insulin release from isolated, perifused adult rat islets of Langerhans. J Endocrinol 153:15-25.
67. Hoeflich A, Nedbal S, Blum WF, et al. 2001. Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2. Endocrinology 142:1889-1898.
68. Hogg J, Han VK, Clemmons DR, Hill DJ. 1993. Interactions of nutrients, insulin-like growth factors (IGFs) and IGF-binding proteins in the regulation of DNA synthesis by isolated fetal rat islets of Langerhans. J Endocrinol 138:401-412.
69. Hogg J, Hill DJ, Han VK. 1994. The ontogeny of insulin-like growth factor (IGF) and IGF-binding protein gene expression in the rat pancreas. J Mol Endocrinol 13:49-58.
70. Holgado-Madruga M, Emlet DR, Moscatello DK, et al. 1996. A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 379:560-564.
71. Holzenberger M, Martin-Crespo RM, Vicent D, Ruiz-Torres A. 1991. Decelerated growth and longevity in men. Arch Gerontol Geriat 13:89-101.
72. Holzenberger M, Dupont J, Ducos B, et al. 2003. IGF-1 receptor regulates life span and resistance to oxidative stress in mice. Nature 421:182-187.
73. Hoog A, Grimelius L, Falkmer S, Sara VR. 1993. A high-molecular IGF-2 immunoreactive peptide (pro-IGF-2?) in the insulin cells of the islets of Langerhans in pancreas of man and rat. Regul Pept 47:275-283.
74. Hutchinson J, Jin J, Cardiff RD, et al. 2001. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol Cell Biol 21:2203-2212.
75. Imagawa W, Bandyopadhyay GK, Nandi S. 1990. Regulation of mammary epithelial cell growth in mice and rats. Endocr Rev 11:494-523.
76. James PL, Jones SB, Busby WH Jr, et al. 1993. A highly conserved insulin-like growth factor-binding protein (IGFBP-5) is expressed during myoblast differentiation. J Biol Chem 268:22305-22312.
77. Kenyon C, Chang J, Gensch E, et al. 1993. A C. elegans mutant that lives twice as long as wild type. Nature 366:461-464.
78. Kimura KD, Tissenbaum HA, Liu Y, Ruvkun G. 1997. Daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277:942-946.
79. Kleinberg DL, Feldman M, Ruan W. 2000. IGF-I: an essential factor in terminal end bud formation and ductal morphogenesis. J Mammary Gland Biol Neoplasia 5:7-17.
80. Kornfeld S. 1992. Structure and function of the mannose 6-phosphate/insulin-like growth factor II receptors. Annu Rev Biochem 61:307-330.
81. Krzisnik C, Kolacio Z, Battelino T, et al. 1999. The "Little People" of the island of Krk - revisited. Etiology of hypopituitarism revealed. J Endocr Genet 1:9-19.
82. Kubota A, Yonekura T, Usui N, et al. 2000. Two cases of persistent hyperinsulinemic hypoglycemia that showed spontaneous regression and maturation of the Langerhans islets. J Pediatr Surg 35:1661-1662.
83. Kulkarni RN, Holzenberger M, Shih DQ, et al. 2002. β-cell-specific deletion of the Igf-1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter β-cell mass. Nat Genet 31:111-115.
84. Kushner JA, Ye J, Schubert Met al. 2002. Pdx1 restores beta cell function in Irs2 knockout mice. J Clin Invest 109:1193-1201.
85. Lalani R, Bhasin S, Byhower F, et al. 2000. Myostatin and insulin-like growth factor-I and -II expression in the muscle of rats exposed to the microgravity environment of the NeuroLab space shuttle flight. J Endocrinol 167:417-428.
86. Laron Z, Klinger B, Silbergeld A. 1998. Patients with Laron syndrome have osteopenia/osteoporosis. J Bone Miner Res 14:156-157.
87. Lauro D, Kido Y, Hayashi H, et al. 1999. Expression of kinase-inactive mutant insulin receptors does not rescue insulin receptor-deficient mice from perinatal death. Diabetologia 42:1441-1442.
88. Lavan BE, Lane WS, Lienhard GE. 1997a. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J Biol Chem 272:11439-11443.
89. Lavan BE, Fantin VR, Chang ET, et al. 1997b. A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J Biol Chem 272:21403-21407.
90. Lee AV, Zhang P, Ivanova M, et al. 2003. Developmental and hormonal signals dramatically alter the localization and abundance of insulin receptor substrate proteins in the mammary gland. Endocrinology 144:2683-2694.
91. Leevers SJ, Weinkove D, MacDougall LK, et al. 1996. The Drosophila phosphoinositide 3-kinase Dp110 promotes cell growth. EMBO J 15:6584-6594.
92. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr. 1995. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16:143-163.
93. Levy MJ, Hernandez ER, Adashi EY, et al. 1992. Expression of the insulin-like growth factor (IGF)-I and -II and the IGF-I and -II receptor genes during postnatal development of the rat ovary. Endocrinology 131:1202-1206.
94. Li G, Robinson GW, Lesche R, et al. 2002. Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland. Development 129:4159-4170.
95. Ligensa T, Krauss S, Demuth D, et al. 2001. A PDZ domain protein interacts with the C-terminal tail of the insulin-like growth factor-1 receptor but not with the insulin receptor. J Biol Chem 276:33419-33427.
96. Lin K, Hsin H, Libina N, Kenyon C. 2001. Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling. Nat Genet 28:139-145.
97. Lingohr MK, Dickson LM, McCuaig JF, et al. 2002. Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation. Diabetes 51:966-976.
98. Liu JP, Baker J, Perkins AS, et al. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type I receptor (Igf1r). Cell 75:59-72.
99. Mathews LS, Hammer RE, Brinster RL, Palmiter RD. 1988. Expression of insulin-like growth factor I in transgenic mice with elevated levels of growth hormone is correlated with growth. Endocrinology 123:433-437.
100. Matsumoto T, Tsurumoto T, Goldring MB, Shindo H. 2000. Differential effects of IGF-binding proteins, IGFBP-3 and IGFBP-5, on IGF-I action and binding to cell membranes of immortalized human chondrocytes. J Endocrinol 166:29-37.
101. Migliaccio E, Giorgio M, Mele S, et al. 1999. The p66SHC adaptor protein controls oxidative stress response and life span in mammals. Nature 402:309-313.
102. Mihaylova VT, Borland CZ, Manjarrez L, et al. 1999. The PTEN tumor suppressor homolog in Caenorhabditis elegans regulates longevity and dauer formation in an insulin receptor-like signaling pathway. Proc Natl Acad Sci U S A 96:7427-7432.
103. Miller RA, Chrisp C, Atchley W. 2000. Differential longevity in mouse stocks selected for early life growth trajectory. J Gerontol A Biol Sci 55:B455-B461.
104. Miyakoshi N, Richman C, Kasukawa Y, et al. 2001. Evidence that IGF-binding protein-5 functions as a growth factor. J Clin Invest 107:73-81.
105. Modric T, Silha JV, Shi Z, et al. 2001. Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice. Endocrinology 142:1958-1967.
106. Moodie SA, Alleman-Sposeto J, Gustafson TA. 1999. Identification of the APS protein as a novel insulin receptor substrate. J Biol Chem 274:11186-11193.
107. Moorehead RA, Fata JE, Johnson MB, Khokha R. 2001. Inhibition of mammary epithelial apoptosis and sustained phosphorylation of Akt/PKB in MMTV-IGF-II transgenic mice. Cell Death Differ 8:16-29.
108. Murakami S, Salmon A, Miller RA. 2003. Multiplex stress resistance in cells from long-lived dwarf mice. FASEB J 17:1565-1566.
109. Murphy CT, McCarroll SA, Bargmann CI, et al. 2003. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424:277-283.
110. Murphy LJ, Rajkumar K, Molnar P. 1995. Phenotypic manifestations of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 overexpression in transgenic mice. Prog Growth Factor Res 6:425-432.
111. Murphy LJ. 2000. Overexpression of insulin-like growth factor binding protein-1 in transgenic mice. Pediatr Nephrol 14:567-571.
112. Musaro A, McCullagh K, Paul A, et al. 2001. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 27:195-200.
113. Napoli C, Martin-Padura I, de Nigris F, et al. 2003. Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proc Natl Acad Sci U S A 100:2112-2116.
114. Neuenschwander S, Schwartz A, Wood TL, et al. 1996. Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model. J Clin Invest 97:2225-2232.
115. Ni W, Rajkumar K, Nagy JI, Murphy LJ. 1997. Impaired brain development and reduced astrocyte response to injury in transgenic mice expressing IGF binding protein-1. Brain Res 769:97-107.
116. Ogata N, Chikazu D, Kubota N, et al. 2000. Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover. J Clin Invest 105:935-943.
117. Olson EN, Williams RS. 2000. Calcineurin signaling and muscle remodeling. Cell 101:689-692.
118. Ookuma S, Fukuda M, Nishida E. 2003. Identification of a DAF-16 transcriptional target gene, scl-1, that regulates longevity and stress resistance in Caenorhabditis elegans. Curr Biol 13:427-431.
119. Pandini G, Frasca F, Mineo R, et al. 2002. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. J Biol Chem 277:39684-39695.
120. Paradis S, Ruvkun G. 1998. Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev 12:2488-2498.
121. Patti ME, Sun XJ, Bruening JC, et al. 1995. 4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice. J Biol Chem 270:24670-24673.
122. Pelicci G, Lanfrancone L, Grignani F, et al. 1992. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70:93-104.
123. Pende M, Kozma SC, Jaquet M, et al. 2000. Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-deficient mice. Nature 408:994-997.
124. Petrik J, Pell JM, Arany E, et al. 1999. Overexpression of insulin-like growth factor-II in transgenic mice is associated with pancreatic islet cell hyperplasia. Endocrinology 140:2353-2363.
125. Pons S, Torres-Aleman I. 1992. Basic fibroblast growth factor modulates insulin-like growth factor-I, its receptor, and its binding proteins in hypothalamic cell cultures. Endocrinology 131:2271-2278.
126. Powell-Braxton L, Hollingshead P, Warburton C, et al. 1993. IGF-I is required for normal embryonic growth in mice. Genes Dev 7:2609-2617.
127. Rabinovitch A, Quigley C, Russell T, et al. 1982. Insulin and multiplication stimulating activity (an insulin-like growth factor) stimulate islet (beta-cell replication in neonatal rat pancreatic monolayer cultures. Diabetes 31:160-164.
128. Rajah R, Khare A, Lee PD, Cohen P. 1999. Insulin-like growth factor-binding protein-3 is partially responsible for high-serum-induced apoptosis in PC-3 prostate cancer cells. J Endocrinol 163:487-494.
129. Rajkumar K, Krsek M, Dheen ST, Murphy LJ. 1996. Impaired glucose homeostasis in insulin-like growth factor binding protein-1 transgenic mice. J Clin Invest 98:1818-1825.
130. Reik W, Constancia M, Dean W, et al. 2000. Igf2 imprinting in development and disease. Int J Dev Biol 44:145-150.
131. Richman C, Baylink DJ, Lang K, et al. 1999. Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo. Endocrinology 140:4699-4705.
132. Roberts RC. 1961. The lifetime growth and reproduction of selected strains of mice. Heredity 16:369-381.
133. Rosen CJ. 1999. Serum insulin-like growth factors and insulin-like growth factor-binding proteins: clinical implications. Clin Chem 45:1384-1390.
134. Rother KI, Accili D. 2000. Role of insulin receptors and IGF receptors in growth and development. Pediatr Nephrol 14:558-561.
135. Rouault JP, Kuwabara PE, Sinilnikova OM, et al. 1999. Regulation of dauer larva development in Caenorhabditis elegans by daf-18, a homologue of the tumour suppressor PTEN. Curr Biol 9:329-332.
136. Saito T, Akutsu S, Urushiyama T, et al. 2003. Changes in the mRNA expressions of insulin-like growth factors, their receptors, and binding proteins during the postnatal development of rat masseter muscle. Zoolog Sci 20:441-447.
137. Salih D, Szestak T, Eisenman E, et al. 2001. Overexpression of IGFBP-5 induces severe growth retardation in mice. Program and Abstracts of the Annual Meeting of the Endocrine Society, Denver, p 74.
138. Samaras TT, Storms LH. 1992. Impact of height and weight on life span. Bull World Health Org 70:259-267.
139. Schwertfeger KL, Richert MM, Anderson SM. 2001. Mammary gland involution is delayed by activated Akt in transgenic mice. Mol Endocrinol 15:867-881.
140. Schwertfeger KL, McManaman JL, Palmer CA, et al. 2003. Expression of constitutively activated Akt in the mammary gland leads to excess lipid synthesis during pregnancy and lactation. J Lipid Res 44:1100-1112.
141. Silha JV, Murphy LJ. 2002. Insights from insulin-like growth factor binding protein transgenic mice. Endocrinology 143:3711-3714.
142. Sjogren K, Liu JL, Blad K, et al. 1999. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci U S A 96:7088-7092.
143. Spagnoli A, Hwa V, Horton WA, et al. 2001. Antiproliferative effects of insulin-like growth factor-binding protein-3 in mesenchymal chondrogenic cell line RCJ3.1C5.18. Relationship to differentiation stage. J Biol Chem 276:5533-5540.
144. Stull MA, Richert MM, Loladze AV, Wood TL. 2002. Requirement for IGF-I in epidermal growth factor-mediated cell cycle progression of mammary epithelial cells. Endocrinology 143:1872-1879.
145. Sun XJ, Rothenberg P, Kahn CR, et al. 1991. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352:73-77.
146. Tatar M, Kopelman A, Epstein D, et al. 2001. A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 292:107-110.
147. Tonner E, Barber MC, Allan GJ, et al. 2002. Insulin-like growth factor binding protein-5 (IGFBP-5) induces premature cell death in the mammary glands of transgenic mice. Development 129:4547-4557.
148. Torres-Aleman I, Naftolin F, Robbins RJ. 1990. Trophic effects of insulin-like growth factor-I on fetal rat hypothalamic cells in culture. Neuroscience 35:601-608.
149. Tuttle RL, Gill NS, Pugh W, et al. 2001. Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nat Med 7:1133-1137.
150. Ullrich A, Gray A, Tam AW, et al. 1986. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 10:2503-2512.
151. Van Schravendijk CF, Foriers A, Van den Brande JL, Pipeleers DG. 1987. Evidence for the presence of type I insulin-like growth factor receptors on rat pancreatic A and B cells. Endocrinology 121:1784-1788.
152. Verdu J, Buratovich MA, Wilder EL, Birnbaum MJ. 1999. Cell-autonomous regulation of cell and organ growth in Drosophila by Akt/PKB. Nat Cell Biol 1:500-506.
153. Wang J, Niu W, Witte DP, et al. 1998. Overexpression of insulin-like growth factor-binding protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle alpha-actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia. Endocrinology 139:2605-2614.
154. Weber MS, Boyle PL, Corl BA, et al. 1998. Expression of ovine insulin-like growth factor-1 (IGF-1) stimulates alveolar bud development in mammary glands of transgenic mice. Endocrine 8:251-259.
155. Werther GA, Cheesman H, Russo V. 1993. Olfactory bulb organ culture is supported by combined insulin-like growth factor-I and basic fibroblast growth factor. Brain Res 617:339-342.
156. Withers DJ, Gutierrez JS, Towery H, et al. 1998. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900-904.
157. Withers DJ, Burks DJ, Towery HH, et al. 1999. Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat Genet 23:32-40.
158. Withers DJ. 2001. Insulin receptor substrate proteins and neuroendocrine function. Biochem Soc Trans 29:525-529.
159. Wolkow CA, Kimura KD, Lee MS, Ruvkun G. 2000. Regulation of C. elegans lifespan by insulin-like signaling in the nervous system. Science 290:147-150.
160. Woods KA, Camacho-Hubner C, Savage MO, Clark AJL. 1996. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 335:1363-1367.
161. Wylie AA, Pulford DJ, McVie-Wylie AJ, et al. 2003. Tissue-specific inactivation of murine M6P/IGF2R. Am J Pathol 162:321-328.
162. Yakar S, Liu JL, Stannard B, et al. 1999. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci U S A 96:7324-7329.
163. Yamane A, Mayo M, Shuler C, et al. 2000. Expression of myogenic regulatory factors during the development of mouse tongue striated muscle. Arch Oral Biol 45:71-78.
164. Ye P, Carson J, D'Ercole AJ. 1995. In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice. J Neurosci 15:7344-7356.
165. Zapf J. 1995. Physiological role of the insulin-like growth factor binding proteins. Eur J Endocrinol 132:645-654.
166. Zhang M, Xuan S, Bouxsein ML, et al. 2002. Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 277:44005-44012.
167. Zhang M, Faugere MC, Malluche H, et al. 2003. Paracrine overexpression of IGFBP-4 in osteoblasts of transgenic mice decreases bone turnover and causes global growth retardation. J Bone Miner Res 18:836-843.
168. Zhao G, Monier-Faugere MC, Langub MC, et al. 2000. Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 141:2674-2682.
169. Zhou J, Kumar TR, Matzuk MM, Bondy C. 1997. Insulin-like growth factor I regulates gonadotropin responsiveness in the murine ovary. Mol Endocrinol 11:1924-1933.